xEL

Revolutionizing Quantum Computing: ORCA Delivers Groundbreaking PT-2 System to the UK

Revolutionizing Quantum Computing: ORCA Delivers Groundbreaking PT-2 System to the UK

ORCA Computing has unveiled the PT-2 photonic quantum system, shipped to the UK’s National Quantum Computing Centre, marking a leap in quantum capabilities. PT-2 features 40 qumodes and integrates with GPUs, advancing hybrid quantum-classical applications for AI and HPC environments. Operating at
March 14, 2025
Revolutionizing Breast Cancer Treatment: The Emerging Arsenal Against HER2-Positive Disease

Revolutionizing Breast Cancer Treatment: The Emerging Arsenal Against HER2-Positive Disease

The treatment of HER2-positive breast cancer is rapidly evolving with innovative, personalized therapies matched to unique tumor characteristics. A diverse selection of treatments includes monoclonal antibodies, HER2-targeted tyrosine kinase inhibitors, and antibody-drug conjugates, empowering oncologists with strategic flexibility. Personalized medicine focuses on
March 7, 2025